BioCentury | Apr 29, 2013
Financial News

Radius Health completes venture financing

...Type: Venture financing Raised: $43 million Investors: F2 Biosciences; Biotech Growth; MPM Capital; Brookside Capital; MPM Bio IV NVS Strategic Fund...
BioCentury | Apr 26, 2013
Financial News

Radius raises $43 million in series B

...round led by new investor F2 Biosciences. Existing investors Biotech Growth; MPM Capital; Brookside Capital; MPM Bio IV NVS Strategic Fund...
BioCentury | May 30, 2011
Financial News

Radius Health completes venture financing

...Raised: $22 million Investors: BB Biotech AG; Brookside Capital; Saints Capital; Nordic Bioscience; Ipsen S.A.; MPM Bio IV NVS Strategic Fund...
BioCentury | Nov 22, 2010
Finance

Amgen's Ven Biogram

...firms, including CMEA Capital (see BioCentury, Sept. 13). MPM Capital manages the Novartis option fund, MPM Bio IV NVS Strategic Fund...
BioCentury | Nov 22, 2010
Finance

On To The Next One

...and cardiovascular play Aires Pharmaceuticals Inc. will be the last deal out of its first MPM Bio IV NVS Strategic Fund...
BioCentury | Nov 15, 2010
Company News

Aires, Novartis deal

...in a series B round led by new investor MPM Capital on behalf of the MPM Bio IV NVS Strategic Fund...
BioCentury | Nov 15, 2010
Financial News

Aires completes venture financing

...Diego, Calif. Business: Cardiovascular, Pulmonary Date completed: 11/11/10 Type: Venture financing Raised: $20 million Investors: MPM Bio IV NVS Strategic Fund...
BioCentury | Nov 12, 2010
Financial News

Aires raises $20M, grants Novartis option

...details were not disclosed. New investor MPM Capital led the round on behalf of the MPM Bio IV NVS Strategic Fund...
BioCentury | May 25, 2009
Finance

Ebb & Flow

...$12 million in a series B2 round led by MPM Capital on behalf of the MPM Bio IV NVS Strategic Fund...
BioCentury | May 25, 2009
Strategy

Wait and see deal

...and you just can't get that kind of money now," said Foley, who manages the MPM Bio IV NVS Strategic Fund...
Items per page:
1 - 10 of 12
BioCentury | Apr 29, 2013
Financial News

Radius Health completes venture financing

...Type: Venture financing Raised: $43 million Investors: F2 Biosciences; Biotech Growth; MPM Capital; Brookside Capital; MPM Bio IV NVS Strategic Fund...
BioCentury | Apr 26, 2013
Financial News

Radius raises $43 million in series B

...round led by new investor F2 Biosciences. Existing investors Biotech Growth; MPM Capital; Brookside Capital; MPM Bio IV NVS Strategic Fund...
BioCentury | May 30, 2011
Financial News

Radius Health completes venture financing

...Raised: $22 million Investors: BB Biotech AG; Brookside Capital; Saints Capital; Nordic Bioscience; Ipsen S.A.; MPM Bio IV NVS Strategic Fund...
BioCentury | Nov 22, 2010
Finance

Amgen's Ven Biogram

...firms, including CMEA Capital (see BioCentury, Sept. 13). MPM Capital manages the Novartis option fund, MPM Bio IV NVS Strategic Fund...
BioCentury | Nov 22, 2010
Finance

On To The Next One

...and cardiovascular play Aires Pharmaceuticals Inc. will be the last deal out of its first MPM Bio IV NVS Strategic Fund...
BioCentury | Nov 15, 2010
Company News

Aires, Novartis deal

...in a series B round led by new investor MPM Capital on behalf of the MPM Bio IV NVS Strategic Fund...
BioCentury | Nov 15, 2010
Financial News

Aires completes venture financing

...Diego, Calif. Business: Cardiovascular, Pulmonary Date completed: 11/11/10 Type: Venture financing Raised: $20 million Investors: MPM Bio IV NVS Strategic Fund...
BioCentury | Nov 12, 2010
Financial News

Aires raises $20M, grants Novartis option

...details were not disclosed. New investor MPM Capital led the round on behalf of the MPM Bio IV NVS Strategic Fund...
BioCentury | May 25, 2009
Finance

Ebb & Flow

...$12 million in a series B2 round led by MPM Capital on behalf of the MPM Bio IV NVS Strategic Fund...
BioCentury | May 25, 2009
Strategy

Wait and see deal

...and you just can't get that kind of money now," said Foley, who manages the MPM Bio IV NVS Strategic Fund...
Items per page:
1 - 10 of 12